Loading graphs…
AI Summary
StalkOIH remains in a Stage 4 decline with sequential lower highs and lower lows beneath its short- and intermediate-term EMAs, and the medium-term bias is firmly bearish as supply continues to dominate. A recent oversold bounce into the declining 9 and 20 EMA lacks rejection, offering no clean sell timing. The recommendation is to defer selling and trim into the EMA resistance zone and prior support-turned-resistance level under a patient stance, while watching for potential stabilization that could postpone further decline.